Vaginal Swab Detects Molecular Signals for Endometrial Cancer
A peer-reviewed study suggests molecular signatures can be identified without invasive uterine sampling using whole-transcriptome sequencing and machine learning.
Read MorePosted by CLP Edit Staff | Apr 6, 2026 | Molecular Diagnostics, Womens Health |
A peer-reviewed study suggests molecular signatures can be identified without invasive uterine sampling using whole-transcriptome sequencing and machine learning.
Read MorePosted by CLP Edit Staff | Mar 26, 2026 | Lab Management |
A national eMERGE study found that genetic risk results can be returned at scale, with over 70% of high-risk patients receiving counseling, though disparities in access persist, according to the American Journal of Human Genetics.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Cancer |
Hims & Hers Health is now offering GRAIL’s Galleri multi-cancer blood test through its digital health platform, expanding access to screening for more than 50 cancer types, including those lacking established protocols.
Read MorePosted by CLP Edit Staff | Feb 9, 2026 | Cancer |
Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.
Read MorePosted by CLP Edit Staff | Feb 2, 2026 | Cancer |
GRAIL has submitted an FDA premarket approval application for its Galleri multi-cancer early detection test, supported by data from more than 25,000 participants in US and UK clinical trials.
Read More